• The Membership Club
  • #EndSARS Dashboard
  • PT Hausa
  • About Us
  • Advert Rates
  • Careers
  • Contact Us
  • Digital Store
Tuesday, January 31, 2023
Premium Times Nigeria
  • Home
  • Gender
  • News
    • Headline Stories
    • Top News
    • More News
    • Foreign
  • Investigations
  • Business
    • News Reports
    • Financial Inclusion
    • Analysis and Data
    • Business Specials
    • Opinion
    • Oil/Gas Reports
      • FAAC Reports
      • Revenue
  • Opinion
  • Health
    • News Reports
    • Special Reports and Investigations
      • Health Specials
    • Features and Interviews
    • Multimedia
    • Primary Health Tracker
  • Agriculture
    • News Report
    • Special Reports/Investigations
    • Features and Interviews
    • Multimedia
  • Arts/Life
    • Arts/Books
    • Kannywood
    • Lifestyle
    • Music
    • Nollywood
    • Travel
  • Sports
    • Football
    • More Sports News
    • Sports Features
  • Projects & Partnerships
    • AUN-PT Data Hub
    • #EndSARS Dashboard
    • Parliament Watch
    • #PandoraPapers
    • Panama Papers
    • Paradise Papers
    • AGAHRIN
  • Home
  • Gender
  • News
    • Headline Stories
    • Top News
    • More News
    • Foreign
  • Investigations
  • Business
    • News Reports
    • Financial Inclusion
    • Analysis and Data
    • Business Specials
    • Opinion
    • Oil/Gas Reports
      • FAAC Reports
      • Revenue
  • Opinion
  • Health
    • News Reports
    • Special Reports and Investigations
      • Health Specials
    • Features and Interviews
    • Multimedia
    • Primary Health Tracker
  • Agriculture
    • News Report
    • Special Reports/Investigations
    • Features and Interviews
    • Multimedia
  • Arts/Life
    • Arts/Books
    • Kannywood
    • Lifestyle
    • Music
    • Nollywood
    • Travel
  • Sports
    • Football
    • More Sports News
    • Sports Features
  • Projects & Partnerships
    • AUN-PT Data Hub
    • #EndSARS Dashboard
    • Parliament Watch
    • #PandoraPapers
    • Panama Papers
    • Paradise Papers
    • AGAHRIN
Premium Times Nigeria
BUA Group Ad BUA Group Ad BUA Group Ad
WHO Director-General, Tedros Adhanom Ghebreyesus [Photo: Scrol.in]

WHO Director-General, Tedros Adhanom Ghebreyesus [Photo: Scrol.in]

COVID-19: WHO suspends trial of hydroxychloroquine over safety concerns

byNike Adebowale-Tambe
May 25, 2020
Reading Time: 2 mins read
0

A clinical trial of hydroxychloroquine as a potential treatment for COVID-19 has been ’temporarily’ suspended by the World Health Organisation (WHO).

The Director-General of the UN health agency, Tedros Ghebreyesus, in a virtual press conference on Monday said the decision follows a study in the Lancet indicating that use of the drug on COVID-19 patients could increase their likelihood of dying.

The cited study, titled “Chloroquine or hydroxychloroquine for COVID-19: Why might they be hazardous?” published on Friday, highlighted that patients who took chloroquine, which hydroxychloroquine is derived from, were also more likely to develop irregular heart rhythms.

Mr Ghebreyesus also said the executive group of the Solidarity Trial, in which hundreds of hospitals across several countries have enrolled patients to test several possible treatments for the virus, had as a precaution, suspended trials using that drug.

“The executive group has implemented a temporary pause of the hydroxychloroquine arm within the Solidarity Trial while the data is reviewed by the Data Safety Monitoring Board.

“The other arms of the trial are continuing,” he said.

He also said this decision only applies to the use of the hydroxychloroquine and chloroquine in COVID-19 patients.

“I wish to reiterate that these drugs are accepted as generally safe for use in patients with autoimmune diseases or malaria, ” he said.

Atiku-Okowa AD

Chloroquine for COVID-19?

Chloroquine is a synthetic drug introduced in the 1940s. It is a member of an important series of chemically related agents known as quinoline derivatives. Hydroxychloroquine is a related compound that was introduced in 1955.

Both drugs are used in the treatment of tropical diseases such as malaria and amebiasis, a parasitic disease also known as amebic dysentery.

They are also useful in the treatment of various skin conditions and diseases of the joints such as rheumatoid arthritis and lupus.

U.S. President Donald Trump had at a press briefing in the White House said he had been using hydroxychloroquine to protect himself against COVID-19.

NAHCON State AD NAHCON Tour Operator AD NAHCON Cargo Operator AD

Kogi AD

TEXEM Advert

However, Nigeria’s Presidential Task Force (PTF) on coronavirus at a daily briefing warned Nigerians against using the drug.

It said the drug has not been declared a cure for the disease and further warned of the possibility of chloroquine poisoning if one indulges in self-medication with the drug.

But Bauchi State governor, Bala Mohammed, who was the index case of COVID-19 in his state, had told journalists early this month that he was administered with chloroquine, zithromax, and Vitamin C during his successful treatment for the disease.

Dangote adbanner 728x90_2 (1)

The governor said COVID-19 patients in the state would, henceforth, be treated with the drugs.

He also said he would rather ask medics managing the state’s COVID-19 patients to treat them with chloroquine and zithromax “than watch them die of the disease.”

Meanwhile, the National Agency for Food Administration and Control (NAFDAC), in an apparent reaction to the governor’s statement, warned Nigerians “not to use any drug for the treatment of COVID-19 that is not approved by the NCDC”.

“The agency is concerned about reports on social and other media of drugs or vaccines to cure COVID 19,” NAFDAC’s Director-General, Mojisola Adeyeye, had said in a statement.

Share this:

  • Twitter
  • Facebook
  • WhatsApp
  • Telegram
  • LinkedIn
  • Email
  • Print



Support PREMIUM TIMES' journalism of integrity and credibility

Good journalism costs a lot of money. Yet only good journalism can ensure the possibility of a good society, an accountable democracy, and a transparent government.

For continued free access to the best investigative journalism in the country we ask you to consider making a modest support to this noble endeavour.

By contributing to PREMIUM TIMES, you are helping to sustain a journalism of relevance and ensuring it remains free and available to all.

Donate



TEXT AD: Call Willie - +2348098788999






PT Mag Campaign AD

Previous Post

Lawyer asks court to declare NSIA illegal

Next Post

Two new cases of COVID-19 detected at FMC Abeokuta

Nike Adebowale-Tambe

Nike Adebowale-Tambe

Nike Adebowale covers the health beat.  She holds a degree from Ekiti State University, Ado Ekiti. Twitter: @nikeadebowale1 

More News

Fulani Coalition Leaders

Governments, other ethnic groups ‘working to destroy cattle rearing’ – Fulani herders

January 31, 2023
The Emir of Dutse in Jigawa State, Nuhu Muhammad-Sanusi

Emir of Dutse dies at 79

January 31, 2023
Shops in Byazhin community, Kubwa, FCT

Inability to access credit trapping farmers in poverty in Abuja rural communities

January 31, 2023
Rukayat Shittu youngest APC flag bearer in Nigeria.

How I emerged candidate, finance my campaign – ‘Youngest’ APC candidate

January 31, 2023

Fuel Scarcity: INEC meets NNPCL on availability of products for election logistics

January 31, 2023
The accident scene at the Ojuelegba area of Lagos state

Ojuelegba Accident: Lagos govt names victims, urges police on investigation

January 31, 2023
Leave Comment

Our Digital Network

  • PT Hausa
  • Election Centre
  • Human Trafficking Investigation
  • Centre for Investigative Journalism
  • National Conference
  • Press Attack Tracker
  • PT Academy
  • Dubawa
  • LeaksNG
  • Campus Reporter

Resources

  • Oil & Gas Facts
  • List of Universities in Nigeria
  • LIST: Federal Unity Colleges in Nigeria
  • NYSC Orientation Camps in Nigeria
  • Nigeria’s Federal/States’ Budgets since 2005
  • Malabu Scandal Thread
  • World Cup 2018
  • Panama Papers Game
  • Our Digital Network
  • About Us
  • Resources
  • Projects
  • Data & Infographics
  • DONATE

All content is Copyrighted © 2022 The Premium Times, Nigeria

No Result
View All Result
  • Digital Store
  • Home
  • News
    • Headline Stories
    • Top News
    • More News
    • Foreign
  • Investigations
  • Gender
  • Business
    • News Reports
    • Financial Inclusion
    • Analysis and Data
    • Business Specials
    • Opinion
    • Oil/Gas Reports
      • FAAC Reports
      • Revenue
  • Health
    • COVID-19
    • News Reports
    • Investigations
    • Data and Infographics
    • Health Specials
    • Features
    • Events
    • Primary Health Tracker
  • Agriculture
    • News Report
    • Research & Innovation
    • Data & Infographics
    • Special Reports/Investigations
    • Investigations
    • Interviews
    • Multimedia
  • Arts/Life
    • Arts/Books
    • Kannywood
    • Lifestyle
    • Music
    • Nollywood
    • Travel
  • Sports
    • Football
    • More Sports News
    • Sports Features
  • #EndSARS Dashboard
  • AUN-PT Data Hub
  • Projects
    • Panama Papers
    • Paradise Papers
    • Parliament Watch
    • AGAHRIN
  • Opinion
  • PT Hausa
  • The Membership Club
  • DONATE
  • About Us
  • Advert Rates
  • Dubawa NG
  • Careers
  • Contact Us

All content is Copyrighted © 2022 The Premium Times, Nigeria